Here we showed that the SKOV3 CD117+CD44+CSC vaccine elicited strongly anti-ovarian cancer immune responses that significantly led to suppressing tumor growth, decreasing CD117+CD44+CSC and aldehyde dehydrogenase 1 (ALDH1) positive cell populations in tumor tissues in the vaccinated nude mice. This evidence concerns the gene CD44 and neoplasm.